GLP-1 medications were originally developed to treat type 2 diabetes, but are also widely prescribed for weight loss
Calcium oxalate (CaOx) calculi represent one of the predominant forms of renal lithiasis
[2] Here's what Medicare coverage for Foundayo looks like today: For weight loss: The Medicare GLP-1 Bridge (live since July 1, 2026) covers all Foundayo formulations at $50/month for eligible Part D beneficiaries (BMI-based criteria + prior authorization) Your standard Part D plan: Still excludes Foundayo for weight loss by statutethe Bridge is the pathway, not your plan's formulary No carve-out indication: Unlike Zepbound (covered under Part D for sleep apnea), Foundayo is weight-loss focusedso the $50 Bridge is essentially your only Medicare pathway Bottom line: Medicare beneficiaries now have a real weight-loss pathway for Foundayothe $50 Bridge, covering all formulations
In women with PCOS and obesity, metformin has been shown to improve insulin sensitivity, reduce insulin and androgen levels, and ameliorate menstrual cyclicity and ovulation rates 18,19,20
For a side-by-side comparison of these two peptides beyond just reconstitution, our complete semaglutide vs tirzepatide comparison covers efficacy, side effects, dosing schedules, and cost
This patient began weekly 0.75mg dulaglutide injections and developed a widespread, itchy, urticaria-like rash following the fourth injection